-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Mirum Pharmaceuticals, Raises Price Target to $150

Benzinga·04/27/2026 16:47:04
Listen to the news
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Mirum Pharmaceuticals (NASDAQ:MIRM) with a Buy and raises the price target from $130 to $150.